Valuation: Fresenius SE & Co. KGaA

Capitalization 19B 20.11B 17.63B 15.72B 28.39B 1,706B 31.11B 219B 80.91B 700B 75.5B 73.85B 3,037B P/E ratio 2024 *
17x
P/E ratio 2025 * 10.7x
Enterprise value 30.99B 32.78B 28.75B 25.63B 46.3B 2,782B 50.72B 357B 132B 1,141B 123B 120B 4,951B EV / Sales 2024 *
1.43x
EV / Sales 2025 * 1.34x
Free-Float
-
Yield 2024 *
2.52%
Yield 2025 * 2.89%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.21%
1 week+0.15%
Current month+1.95%
1 month+1.25%
3 months+0.12%
6 months+12.47%
Current year+20.84%
More quotes
1 week
33.21
Extreme 33.21
34.21
1 month
31.99
Extreme 31.99
34.21
Current year
24.32
Extreme 24.32
36.24
1 year
24.32
Extreme 24.32
36.24
3 years
19.69
Extreme 19.69
38.11
5 years
19.69
Extreme 19.69
51.54
10 years
19.69
Extreme 19.69
80.07
More quotes
Director TitleAgeSince
Chief Executive Officer 56 2022-09-30
Director of Finance/CFO 44 2022-08-31
Compliance Officer - -
Manager TitleAgeSince
Director/Board Member 75 2011-01-27
Director/Board Member 65 2007-07-15
Director/Board Member 70 2015-05-19
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.22%+0.15%+20.07%-0.62%20.11B
-0.39%-2.79%+23.67%+31.92%80.68B
+1.41%-5.09%-25.34%-42.38%70.56B
+0.60%+9.30%+7.65%+85.34%27.83B
-2.24%-1.19%+188.56%+83.23%22.15B
+1.47%-1.92%+8.96%-16.30%19.74B
+0.54%-2.05%+16.40%+0.30%17.66B
+0.16%+2.99%+19.14%-15.29%14.16B
+1.49%-0.72%+97.08%+88.95%13.41B
-1.37%-3.47%+46.92%+50.43%12.96B
Average +0.67%-0.41%+40.31%+26.56% 29.93B
Weighted average by Cap. +0.64%-1.50%+25.27%+17.06%
See all sector performances

Financials

2024 *2025 *
Net sales 21.73B 22.99B 20.16B 17.98B 32.47B 1,951B 35.57B 251B 92.53B 801B 86.34B 84.46B 3,473B 22.77B 24.09B 21.13B 18.84B 34.03B 2,045B 37.28B 263B 96.96B 839B 90.48B 88.51B 3,639B
Net income 1.13B 1.19B 1.05B 932M 1.68B 101B 1.84B 12.99B 4.8B 41.5B 4.48B 4.38B 180B 1.79B 1.89B 1.66B 1.48B 2.67B 160B 2.92B 20.59B 7.6B 65.78B 7.1B 6.94B 285B
Net Debt 11.98B 12.68B 11.12B 9.91B 17.9B 1,076B 19.62B 138B 51.02B 441B 47.61B 46.57B 1,915B 11.5B 12.17B 10.67B 9.52B 17.19B 1,033B 18.83B 133B 48.98B 424B 45.7B 44.7B 1,838B
More financial data * Estimated data
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Employees
177,091
Calendar
More about the company
Date Price Change Volume
24-12-10 34.01 +0.80% 157,730
24-12-09 33.74 +0.21% 688,975
24-12-06 33.67 -0.88% 764,033
24-12-05 33.97 -0.09% 879,571
24-12-04 34.00 +0.38% 836,865

Delayed Quote Xetra, December 10, 2024 at 03:11 am EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart FRESENIUS-SE-CO-KGAAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
33.74EUR
Average target price
40.86EUR
Spread / Average Target
+21.10%
Consensus

Quarterly revenue - Rate of surprise